Orchid Pharma Calls AGM to Ratify Post-Merger Financials and Key Governance Moves

An update from Orchid Pharma Limited ( (IN:ORCHPHARMA) ) is now available. Orchid Pharma Limited has released its annual report for the financial year 2025-26 and issued notice for its 33rd Annual General Meeting, scheduled for September 29, 2026, to be held via video conferencing and other audio-visual means. The AGM agenda includes adoption of revised standalone and consolidated financial statements following the amalgamation with Dhanuka Laboratories, reappointment of Whole Time Director Mridul Dhanuka, ratification of cost auditor remuneration, and approval of material related party transactions with Otsuka Chemicals (India) Private Limited, underscoring ongoing integration of the merger and governance over key operational and compliance matters. These resolutions highlight Orchid Pharma's efforts to formalize the financial impact of its recently sanctioned amalgamation, maintain board continuity, and strengthen oversight of cost structures and significant related party dealings. For shareholders and other stakeholders, the meeting marks a key step in aligning the company's post-merger financial reporting and governance framework with regulatory requirements while clarifying its strategic relationships within the broader chemical and pharmaceutical supply chain. More about Orchid Pharma Limited Orchid Pharma Limited, a Dhanuka Group company, operates in the pharmaceutical sector with manufacturing facilities in Tamil Nadu and a corporate office in Gurugram. The company is listed on both the National Stock Exchange of India and BSE, reflecting its presence in the Indian capital markets and its focus on regulated, compliance-driven operations. Average Trading Volume: 12,015 Technical Sentiment Signal: Strong Buy Current Market Cap: 48.42B INR For an in-depth examination of ORCHPHARMA stock, go to TipRanks' Overview page. This story was written using TipRanks's AI tools and reviewed by a TipRanks editor. Disclaimer & DisclosureReport an Issue